Abstract:Investigating combined treatment methodologies is crucial for addressing the complex nature of cancer. As an emerging strategy, nano-biotechnology encourages the design of unique nanocarriers possessing simultaneous therapeutic application properties. This study aims to explore the combined effects of photodynamic and anticancer treatments using a multifunctional nanocarrier system co-administering the photosensitizer IR780 and the anticancer agent curcumin (Cur) on lung cancer cells. Nanocarriers were prepared by encapsulation IR780 and Cur inside polyethylene glycol-capped mesoporous silica nanoparticles (Cur&IR780@MSN). Various concentrations of nanocarriers were evaluated on A549 cells following 5 min NIR laser light (continuous wave, 785 nm, 500 mW/cm 2 ) irradiation. The internalization of nanocarriers was observed through the fluorescence of Cur. Changes in cell viability were determined using the MTT assay and AO/PI staining. A scratch assay analysis was also performed to examine the impact of combined treatments on cell migration. Characterization of the nanocarriers revealed adequate hydrophobic drug loading, temperature-inhibited feature, enhanced reactive oxygen species generation, a pH-dependent curcumin release profile, and high biocompatibility. Cur&IR780@MSN, which enabled the observation of synergistic treatment efficacy, successfully reduced cell viability by up to 78%. In contrast, monotherapies with curcumin-loaded nanocarriers (Cur@MSN) and IR780-loaded nanocarriers (IR780@MSN) resulted in a 38% and 56% decrease in cell viability, respectively. The constructed Cur&IR780@MSN nanocarrier has demonstrated remarkable performance in the application of combination therapies for lung cancer cells. These nanocarriers have the potential to inspire future studies in tumor treatment methods.
What problem does this paper attempt to address?
The problem that this paper attempts to solve is how to improve the curative effect and reduce the damage to healthy cells in lung cancer treatment by combining photodynamic therapy (PDT) and anti - cancer drug treatment. Specifically, the researchers designed a multifunctional nano - carrier system (Cur&IR780@MSN), which simultaneously loaded the photosensitizer IR780 and the anti - cancer drug curcumin (Cur) for the combined treatment of lung cancer cells. The main goal of the study was to explore the synergistic effect of this combined treatment method on lung cancer cells, in the hope of finding a more effective cancer treatment method with fewer side effects.
### Research Background
Traditional cancer treatment methods such as chemotherapy, radiotherapy and surgical resection have limitations in dealing with the complex and changeable tumor environment, such as greater side effects on healthy tissues, difficulty in achieving targeted treatment, and difficulty in preventing the metastasis of cancer cells. Therefore, researchers began to explore new treatment methods that have the characteristics of acting on specific parts, have small side effects on healthy tissues, and can prevent the metastasis of cancer cells. The combination of nanotechnology and safe and controllable treatment technologies (such as photodynamic therapy, photothermal therapy or anti - cancer drug therapy) is considered one of the most promising methods to meet these requirements.
### Photodynamic Therapy (PDT)
Photodynamic therapy is an emerging, minimally - invasive tumor treatment method. Its treatment mechanism is to generate reactive oxygen species (ROS) through photosensitizers (PS) and light irradiation in the presence of oxygen, thereby inducing local cytotoxicity and ultimately leading to the death of tumor cells. The effectiveness of PDT mainly depends on the type and concentration of the photosensitizer used, the wavelength, power and duration of light irradiation, and the endogenous oxygen level. Therefore, choosing the appropriate photosensitizer and light irradiation conditions is crucial for the successful implementation of PDT.
### Curcumin
Curcumin is a natural compound extracted from turmeric and has attracted wide attention due to its multiple pharmacological effects, including inhibiting cell proliferation and invasion, inducing cancer cell death mechanisms, and inhibiting tumor metastasis. Curcumin can successfully inhibit the growth of non - small - cell lung cancer cells by regulating metalloproteinases (MMP - 9), epidermal growth factor receptor (EGFR), drug efflux protein P - gp and Bcl - 2/Bax proteins and other pathways.
### Nano - carrier System
In order to overcome the limitations of using photodynamic therapy or curcumin alone for treatment, the researchers developed a polyethylene glycol (PEG) - functionalized mesoporous silica nanoparticle (MSN) as a nano - carrier for simultaneously delivering IR780 and curcumin. This nano - carrier system aims to improve the treatment effect and reduce the damage to healthy cells through a combined treatment strategy.
### Experimental Methods
- **Preparation of Nano - carriers**: Mesoporous silica nanoparticles were prepared by the Stöber method, and then IR780 and curcumin were loaded separately or simultaneously, and finally PEG surface modification was carried out.
- **Characterization of Nano - carriers**: The size, morphology and surface chemical characteristics of the nano - carriers were characterized by means of dynamic light scattering (DLS), scanning electron microscopy (SEM) and Fourier transform infrared spectroscopy (FTIR).
- **Evaluation of Photodynamic Therapy and Anti - cancer Drug Release**: The photodynamic effect and anti - cancer drug release performance of the nano - carriers were evaluated by detecting the generation of ROS and the pH - dependent release of curcumin.
- **Cell Experiments**: The effects of nano - carriers on the cytotoxicity and migration ability of lung cancer cells (A549) were evaluated by methods such as the MTT method, AO/PI staining and scratch test.
### Conclusion
The research results show that the Cur&IR780@MSN nano - carrier system can significantly reduce the survival rate of lung cancer cells, up to 78%, and exhibits good biocompatibility and pH - dependent drug release characteristics. Compared with using curcumin - loaded nano - carriers (Cur@MSN) or IR780 - loaded nano - carriers (IR780@MSN) alone, the combined treatment strategy has a more significant effect on lung cancer cells. This research result provides new ideas for the research of future tumor treatment methods.